Seibersdorf Labor GmbH is currently building the largest production facility in Central Europe for radiopharmaceuticals, which are used in cancer therapy and cancer diagnosis. On 22 May, the successful and accident-free progress of the construction work was celebrated.

In short speeches, Markus Neumann (Managing Director of Seibersdorf Labor GmbH), Alexander Svejkovsky (Managing Director of the parent company AIT Austrian Institute of Technology GmbH) and Roland Müller (Head of Radiopharmacy and future ‘landlord’ of the new laboratory) thanked all those involved in the planning and construction teams. The major investment is a flagship project for cancer therapy and will ensure the care of patients in Austria. However, the high-quality products from Seibersdorf are also supplied to other European countries and overseas.